Lung Cancer - Nashville TN (Clinical Trial 3963) (Clinical Trial 3963)
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please search our
studies.
|
|
 |
 |
|
| City: |
|
Nashville |
| State: |
|
TN |
| Zip Code: |
|
37203 |
|
|
|
|
|
|
|
|
|
|
|
|
| Study summary: |
|
Purpose: To determine if
treatment with motesanib AMG 706 in combination with paclitaxel
and carboplatin improves overall survival compared to
treatment with placebo in combination with paclitaxel
and carboplatin in patients with advanced NSCLC
(non-small cell lung cancer).
lungcancer3952
Inclusion Criteria:
- Histologically confirmed, unresectable
stage 111B with pericardial or pleural effusion or stage IV or recurrent
NSCLC.
- Ability to take oral medications
Exclusion Criteria:
- Any prior chemotherapy for advanced NSCLC
- Pregnant or breastfeeding woman.
 |
|
|
|
|
|
|
| Study is available at: |
|
The Sarah Cannon Research Institute
250 25th Ave., Suite 110
Nashville, TN 37203
View Clinic Location
or
Find Other Clinic Locations
If you meet the above criteria and live within 150 miles of this clinic please click the “View Contact Phone Number” button below to get the clinic’s phone number.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials or take the Participation Quiz to find out if you are a good
candidate for clinical trial participation.
|
|
|
|
|